Remgro slashes dividend after Covid-19 hit to FirstRand and Mediclinic
The investment heavyweight says that excluding FirstRand and Mediclinic, its investee companies were resilient during SA’s second wave
25 March 2021 - 08:14
Remgro, the listed investment holding company chaired by Johann Rupert, says SA’s second wave of Covid-19 hit harder than expected, with group profits more than halving amid pressure on investees FirstRand and Mediclinic.
Remgro described Covid-19’s effect on SA in the second half of 2020 as “devastating”, with the second wave characterised by a new variant of the coronavirus with higher infection rates and greater severity of symptoms...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.